{"data":{"ModuleTitle":{"label":"Module Title","value":"Company Description"},"CompanyName":{"label":"Company Name","value":"ProKidney Corp."},"Symbol":{"label":"Symbol","value":"PROK"},"Address":{"label":"Address","value":"3929 WESTPOINT BOULEVARD,SUITE G SUITE 250, WINSTON-SALEM, North Carolina, 27103, United States"},"Phone":{"label":"Phone","value":"+1 336 999-7029"},"Industry":{"label":"Industry","value":"Biotechnology: Biological Products (No Diagnostic Substances)"},"Sector":{"label":"Sector","value":"Health Care"},"Region":{"label":"Region","value":"North America"},"CompanyDescription":{"label":"Company Description","value":"ProKidney Corp is a clinical-stage biotechnology company with a transformative proprietary cell therapy platform capable of treating multiple chronic kidney diseases using a patient's own cells isolated from the patient intended for treatment. Its lead product candidate, REACT (Renal Autologous Cell Therapy) is a disease-modifying cell therapy made from a patient's own renal cells. REACT has the potential to slow and stabilize the progression of chronic kidney disease."},"CompanyUrl":{"label":"Company Url","value":"https://www.prokidney.com"},"KeyExecutives":{"label":"Key Executives","value":[{"name":"Aparna Sahoo","title":"Vice President & Head-Global Clinical Development"},{"name":"Bruce Culleton","title":"Chief Executive Officer & Director"},{"name":"Joseph Stavas","title":"Senior VP & Head Global Clinical Development"},{"name":"Lucio Tozzi","title":"Senior Vice President-Global Clinical Operations"},{"name":"Richard Williams","title":"Senior Vice President-Information Technology"},{"name":"Ulrich Ernst","title":"Executive Vice President-Technical Operations"}]}},"message":null,"status":{"rCode":200,"bCodeMessage":null,"developerMessage":null}}